[1] Kim MO, Takada LT, Wong K, Forner SA, Geschwind MD. Genetic PrP prion diseases[J]. Cold Spring Harb Perspect Biol, 2018, 10:a033134.
[2] Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases:molecular insights and diagnosis[J]. Lancet Neurol, 2012, 11:618-628.
[3] Yang J, Kuang H, Wang Q, Liu J, Chen X, Shang H. Analysis of Chinese patients with sporadic Creutzfeldt-Jakob disease[J]. Prion, 2020, 14:137-142.
[4] Bernardi L, Bruni AC. Mutations in prion protein gene:pathogenic mechanisms in C-terminal vs. N-terminal domain, a review[J]. Int J Mol Sci, 2019, 20:3606.
[5] Mackenzie G, Will R. Creutzfeldt-Jakob disease:recent developments[J]. F1000Res, 2017, 6:2053.
[6] Thompson AG, Lowe J, Fox Z, Lukic A, Porter MC, Ford L, Gorham M, Gopalakrishnan GS, Rudge P, Walker AS, Collinge J, Mead S. The Medical Research Council prion disease rating scale:a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies[J]. Brain, 2013, 136(Pt 4):1116-1127.
[7] Prodi E, Rossi S, Bertaina I, Pravatà E, Sacco L. Report of a case of Creutzfeldt-Jakob disease with an unusual clinical presentation[J]. Front Behav Neurosci, 2020, 14:55.
[8] Zizi G, Berger H, Lalire P, Dejust S, Morland D. 18F -FDG PET/CT in sporadic Creutzfeldt-Jakob disease[J]. Clin Nucl Med, 2020, 45:538-539.
[9] Kiliç AK, Kaymakamzade B, Saka E, Tan E. The sole initial imaging finding in Creutzfeldt-Jacob disease:focal FDG-PET hypometabolism[J]. Noro Psikiyatr Ars, 2018, 56:226-228.
[10] Mente KP, O'Donnell JK, Jones SE, Cohen ML, Thompson NR, Bizzi A, Gambetti P, Safar JG, Appleby BS. Fluorodeoxyglucose positron emission tomography (FDG-PET) correlation of histopathology and MRI in prion disease[J]. Alzheimer Dis Assoc Disord, 2017, 31:1-7.
[11] Renard D, Castelnovo G, Collombier L, Thouvenot E, Boudousq V. FDG-PET in Creutzfeldt-Jakob disease:analysis of clinical-PET correlation[J]. Prion, 2017, 11:440-453.
[12] Henkel K, Zerr I, Hertel A, Gratz KF, Schröter A, Tschampa HJ, Bihl H, Büll U, Grünwald F, Drzezga A, Spitz J, Poser S. Positron emission tomography with[18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD)[J]. J Neurol, 2002, 249:699-705.
[13] Renard D, Vandenberghe R, Collombier L, Kotzki PO, Pouget JP, Boudousq V. Glucose metabolism in nine patients with probable sporadic Creutzfeldt-Jakob disease:FDG-PET study using SPM and individual patient analysis[J]. J Neurol, 2013, 260:3055-3064.
[14] Kim EJ, Cho SS, Jeong BH, Kim YS, Seo SW, Na DL, Geschwind MD, Jeong Y. Glucose metabolism in sporadic Creutzfeldt-Jakob disease:a statistical parametric mapping analysis of 18 F-FDG PET J. Eur J Neurol, 2012, 19:488-493.
[15] Zhang L, Guo Y, Hu H, Wang J, Liu Z, Gao F. FDG-PET and NeuN-GFAP immunohistochemistry of hippocampus at different phases of the pilocarpine model of temporal lobe epilepsy[J]. Int J Med Sci, 2015, 12:288-294.
[16] Prieto E, Domínguez-Prado I, Riverol M, Ortega-Cubero S, Ribelles MJ, Luquin MR, de Castro P, Arbizu J. Metabolic patterns in prion diseases:an FDG PET voxel-based analysis[J]. Eur J Nucl Med Mol Imaging, 2015, 42:1522-1529.
[17] Ortega-Cubero S, Pagola I, Luquin MR, Viteri C, Pastor P, Gállego Pérez-Larraya J, de Castro P, Domínguez I, Irimia P, Martínez -Vila E, Arbizu J, Riverol M. Clinical and neuroimaging characteristics of 14 patients with prionopathy:a descriptive study[J]. Neurologia, 2015, 30:144-152.
[18] Euskirchen P, Buchert R, Koch A, Schulz-Schaeffer WJ, Schreiber SJ, Sobesky J. Sporadic Creutzfeldt-Jakob disease with mesiotemporal hypermetabolism[J]. J Neurol Sci, 2014, 345:278-280.
[19] Matías-Guiu JA, Guerrero-Márquez C, Cabrera-Martín MN, Gómez -Pinedo U, Romeral M, Mayo D, Porta-Etessam J, Moreno-Ramos T, Carreras JL, Matías-Guiu J. Amyloid-and FDG -PET in sporadic Creutzfeldt-Jakob disease:correlation with pathological prion protein in neuropathology[J]. Prion, 2017, 11:205-213.
[20] Bagyinszky E, Yang Y, Giau VV, Youn YC, An SSA, Kim S. Novel prion mutation (p. Tyr225Cys) in a Korean patient with atypical Creutzfeldt-Jakob disease[J]. Clin Interv Aging, 2019, 14:1387-1397.
[21] George P, Newey CR, Mente KP, Pioro EP. Positron emission tomography imaging in a case of E200K mutation-related spongiform encephalopathy with non-diagnostic magnetic resonance imaging and cerebrospinal fluid testing[J]. SAGE Open Med Case Rep, 2017, 5:2050313X17700347.
[22] Furukawa F, Ishibashi S, Sanjo N, Yamashita H, Mizusawa H. Serial magnetic resonance imaging changes in sporadic Creutzfeldt-Jakob disease with valine homozygosity at codon 129 of the prion protein gene[J]. JAMA Neurol, 2014, 71:1186-1187.
[23] Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis:correlation with autoantibody types[J]. J Neurol, 2013, 260:2744-2753.
[24] Shin YW, Lee ST, Shin JW, Moon J, Lim JA, Byun JI, Kim TJ, Lee KJ, Kim YS, Park KI, Jung KH, Lee SK, Chu K. VGKC-complex/LGI1-antibody encephalitis:clinical manifestations and response to immunotherapy[J]. J Neuroimmunol, 2013, 265:75-81.
[25] Leypoldt F, Buchert R, Kleiter I, Marienhagen J, Gelderblom M, Magnus T, Dalmau J, Gerloff C, Lewerenz J. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis:distinct pattern of disease[J]. J Neurol Neurosurg Psychiatry, 2012, 83:681-686. |